HealthMerck’s drug for diabetes-related eye disease meets trial goal
Merck said Thursday that its injectable drug for a serious eye disease affecting people with diabetes was as effective as the current standard treatment at improving visual sharpness in a clinical trial.
Merck’s drug for diabetes-related eye disease meets trial goal
